DK197286A - Terapeutiske praeparater til detektering og/eller behandling af pattedyrtumorer - Google Patents

Terapeutiske praeparater til detektering og/eller behandling af pattedyrtumorer Download PDF

Info

Publication number
DK197286A
DK197286A DK197286A DK197286A DK197286A DK 197286 A DK197286 A DK 197286A DK 197286 A DK197286 A DK 197286A DK 197286 A DK197286 A DK 197286A DK 197286 A DK197286 A DK 197286A
Authority
DK
Denmark
Prior art keywords
detection
treatment
patient tumors
therapeutic preparations
therapeutic
Prior art date
Application number
DK197286A
Other languages
English (en)
Other versions
DK168690B1 (da
DK197286D0 (da
Inventor
Jerry C Bommer
Bruce F Burnham
Original Assignee
Nippon Petrochemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Petrochemicals Co Ltd filed Critical Nippon Petrochemicals Co Ltd
Publication of DK197286D0 publication Critical patent/DK197286D0/da
Publication of DK197286A publication Critical patent/DK197286A/da
Application granted granted Critical
Publication of DK168690B1 publication Critical patent/DK168690B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK197286A 1985-04-30 1986-04-30 Farmaceutiske præparater til detektion og/eller behandling af pattedyrtumorer DK168690B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72878685A 1985-04-30 1985-04-30
US72878685 1985-04-30

Publications (3)

Publication Number Publication Date
DK197286D0 DK197286D0 (da) 1986-04-30
DK197286A true DK197286A (da) 1987-01-23
DK168690B1 DK168690B1 (da) 1994-05-24

Family

ID=24928279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK197286A DK168690B1 (da) 1985-04-30 1986-04-30 Farmaceutiske præparater til detektion og/eller behandling af pattedyrtumorer

Country Status (8)

Country Link
EP (1) EP0210351B1 (da)
JP (1) JPH0764728B2 (da)
AT (1) ATE91625T1 (da)
AU (1) AU589957B2 (da)
CA (1) CA1291710C (da)
DE (1) DE3688721T2 (da)
DK (1) DK168690B1 (da)
NO (1) NO173319C (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
JPS63192718A (ja) * 1987-02-06 1988-08-10 Hamari Yakuhin Kogyo Kk 肝障害抑制剤
CA1341460C (en) * 1988-01-11 2004-10-19 The Medical College Of Ohio Production and use of porphyrin derivatives and of compositions containing such derivates
US4916711A (en) * 1988-09-29 1990-04-10 Boyer Joseph H Lasing compositions and methods for using the same
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
US4997639A (en) * 1989-11-27 1991-03-05 Nippon Petrochemicals Company, Limited Method for detecting cholesterol deposited in bodies of mammals
US5446157A (en) * 1990-04-23 1995-08-29 Morgan; Lee R. Boron difluoride compounds useful in photodynamic therapy and production of laser light
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
PL317192A1 (en) * 1994-05-13 1997-03-17 Monsanto Co Methods of using pernitrite decomposition catalyst and their pharmaceutic compositions
EP1339862B1 (en) 2000-11-29 2014-01-08 PCI Biotech AS Photochemical internalization for virus-mediated molecule delivery into the cytosol
HU229805B1 (en) 2000-11-29 2014-07-28 Pci Biotech As Photochemical internalization for delivery of molecules into the cytosol
JP2011518891A (ja) * 2009-04-29 2011-06-30 ドイアテクフ コリア シーオー．，エルティーディー． クロリンｅ６−葉酸結合化合物およびキトサンを含有する癌治療用薬学的組成物
RU2537759C1 (ru) * 2013-07-12 2015-01-10 Евгений Валерьевич Жаров Способ фотодинамической терапии онкологических заболеваний
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids
RU2604388C2 (ru) * 2015-04-29 2016-12-10 Евгений Владимирович Давыдов Флуоресцентная диагностика злокачественного новообразования животного

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5819644B2 (ja) 1975-03-13 1983-04-19 ウェルファイド株式会社 スイチユウボウオザイ
JPS53109929A (en) * 1977-03-04 1978-09-26 Nippon Oil Co Ltd Medicin for malignant tumor
JPS5587792A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Meso-tetra(p-carboxyphenyl)porphine derivative
JPS57185220A (en) * 1981-05-07 1982-11-15 Yakult Honsha Co Ltd Carcinostatic agent containing chlorophyll derivative as active component
JPS58981A (ja) * 1981-06-26 1983-01-06 Tama Seikagaku Kk 水溶性ポルフイリン誘導体
US4614190A (en) 1981-09-08 1986-09-30 Alexei Stanco Photoradiation method and arrangement
DE3381616D1 (de) * 1982-09-27 1990-07-05 Photofrin Medical Inc Gereinigte hemaf 3381400inabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren.
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents

Also Published As

Publication number Publication date
AU589957B2 (en) 1989-10-26
CA1291710C (en) 1991-11-05
EP0210351A2 (en) 1987-02-04
JPH0764728B2 (ja) 1995-07-12
NO173319B (no) 1993-08-23
NO861724L (no) 1986-10-31
DK168690B1 (da) 1994-05-24
NO173319C (no) 1993-12-01
DE3688721D1 (de) 1993-08-26
DE3688721T2 (de) 1993-12-16
ATE91625T1 (de) 1993-08-15
JPS625912A (ja) 1987-01-12
EP0210351B1 (en) 1993-07-21
DK197286D0 (da) 1986-04-30
AU5689186A (en) 1986-11-06
EP0210351A3 (en) 1990-09-05

Similar Documents

Publication Publication Date Title
DK197286D0 (da) Terapeutiske praeparater til detektering og/eller behandling af pattedyrtumorer
DK333788D0 (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
NO170480C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
NO882732L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK1188A (da) Bestraalingsandordning til medicinsk behandling af oerer
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
NO865204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzosyre- og benzosyreester-derivater.
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
DK241585A (da) 8-chlor-quinolincarboxylsyre-derivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne forbindelser
NO870049L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO164982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
NO171108C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater
DK603688D0 (da) Middel til behandling af blodhoejtryk og hjerteinsufficiens
ATE58521T1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
NO164099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav.
ATE65396T1 (de) Verwendung von carbonsaeure in fuer topische anwendung vorgesehenen pharmazeutischen zubereitungen.
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
NO864689D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
NO881811D0 (no) Fremgangsmaate og mellomprodukter for fremstilling av n-(s-3-alkylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanin.
FI893001A0 (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1,2-bensisoxazol-3-yl- och 1,2-bensisotiazol -3-ylderivat.
NO881256D0 (no) Fremgangsmaate for fremstilling av 5-hydroksydiprafenon og syreaddisjonssalter derav.

Legal Events

Date Code Title Description
PUP Patent expired